What was the first FDA approved ADC?
The first FDA-approved ADC was gemtuzumab ozogamicin, which was approved in 2000 for the treatment of acute myeloid leukemia. However, it was later withdrawn from the market and then reintroduced in 2017 with new dosing recommendations.